SCHEMBL5334839

SCHEMBL5334839

O=C(NCc1cccs1)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 9/20 0.68
ALDH1A1 P00352 3/20 0.64
USP2 O75604 1/20 0.62
HTT P42858 1/20 0.62
TSHR P16473 1/20 0.59
MAPT P10636 2/20 0.58
NPSR1 Q6W5P4 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
THRB P10828 1/20 0.57
RAB9A P51151 5/20 0.56
NPC1 O15118 2/20 0.56
TAAR1 Q96RJ0 1/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
POLB P06746 3/20 0.55
LMNA P02545 1/20 0.54
MAPK14 Q16539 1/20 0.54
KDM4E B2RXH2 1/20 0.54
TP53 P04637 1/20 0.53
HSD17B10 Q99714 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2400629 0.86 HPGD (0.74) HPGDALDH1A1USP2HTTTSHR
SCHEMBL5341390 0.85 NPC1 (0.77) HPGDALDH1A1HTTMAPTSMN1; SMN2
SCHEMBL11731566 0.83 HPGD (0.69) HPGDALDH1A1USP2HTTTSHR
SCHEMBL2234130 0.81 HPGD (1.00) HPGDALDH1A1USP2HTTSMN1; SMN2
Hydrochloric Acid SCHEMBL28152221 0.80 HPGD (0.97) HPGDALDH1A1USP2HTTSMN1; SMN2
SCHEMBL10322196 0.79 KDM4E (0.60) HPGDALDH1A1USP2HTTTSHR
SCHEMBL11822204 0.78 HPGD (0.62) HPGDALDH1A1USP2HTTTSHR
SCHEMBL10322195 0.77 KDM4E (0.58) HPGDALDH1A1USP2HTTTSHR
SCHEMBL5551614 0.77 HPGD (0.74) HPGDALDH1A1USP2HTTTSHR
SCHEMBL13947125 0.77 HPGD (0.74) HPGDALDH1A1USP2HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
EP-1675844-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE Sterix Limited (GB) 2006-07-05 EP disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed
WO-2005042513-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE STERIX LIMITED (GB) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 HPGD 340/4885ALDH1A1 378/4885USP2 3185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.